Antidiabetic Phytochemicals From Medicinal Plants: Prospective Candidates for New Drug Discovery and Development

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2022 Mar 14

PMID 35282429

Authors

Safaet Alam

Md Moklesur Rahman Sarker

Taposhi Nahid Sultana

Md Nafees Rahman Chowdhury

Mohammad A Rashid

Nusrat Islam Chaity

Chao Zhao

Jianbo Xiao

Elsayed E Hafez

Shah Alam Khan

Isa Naina Mohamed

Affiliations

Soon will be listed here.

Abstract

Diabetes, a chronic physiological dysfunction affecting people of different age groups and severely impairs the harmony of peoples' normal life worldwide. Despite the availability of insulin preparations and several synthetic oral antidiabetic drugs, there is a crucial need for the discovery and development of novel antidiabetic drugs because of the development of resistance and side effects of those drugs in long-term use. On the contrary, plants or herbal sources are getting popular day by day to the scientists, researchers, and pharmaceutical companies all over the world to search for potential bioactive compound(s) for the discovery and development of targeted novel antidiabetic drugs that may control diabetes with the least unwanted effects of conventional antidiabetic drugs. In this review, we have presented the prospective candidates comprised of either isolated phytochemical(s) and/or extract(s) containing bioactive phytoconstituents which have been reported in several , , and clinical studies possessing noteworthy antidiabetic potential. The mode of actions, attributed to antidiabetic activities of the reported phytochemicals and/or plant extracts have also been described to focus on the prospective phytochemicals and phytosources for further studies in the discovery and development of novel antidiabetic therapeutics.

Citing Articles

L. (Oxalidaceae): From Invasive Concern to Promising Bioresource for Health and Sustainable Applications.

Malfa G, Bianchi S, Spadaro V, Di Giacomo C, Raimondo F, Acquaviva R Plants (Basel). 2025; 14(4).

PMID: 40006837 PMC: 11858978. DOI: 10.3390/plants14040578.

Evaluating the effects of seed oils on lipid profile, inflammatory and oxidative markers, and glycemic control of diabetic and dyslipidemic patients: a systematic review of clinical studies.

Fornari Laurindo L, Fornari Laurindo L, Dogani Rodrigues V, da Silva Camarinha Oliveira J, Leme Boaro B, Cressoni Araujo A Front Nutr. 2025; 12:1502815.

PMID: 39996006 PMC: 11849496. DOI: 10.3389/fnut.2025.1502815.

Decne., an endemic and rare subshrub from Arabian desert: antidiabetic and antihyperlipidemic effects of leaf hydroethanolic extracts.

Guetat A, Selmi S, Abdelwahab A, Abdelfattah M, Elhaj A, Mogharbel R Front Pharmacol. 2025; 16:1537071.

PMID: 39995414 PMC: 11847675. DOI: 10.3389/fphar.2025.1537071.

Effect of seeds on Glycated hemoglobin, Cardiovascular disease risks and dyslipidemia in Type-2 diabetic patients in Karachi: A non-blind randomized controlled trial.

Mudassir H, Arshad S, Naheed M, Anwer S Pak J Med Sci. 2025; 41(1):257-262.

PMID: 39867806 PMC: 11755271. DOI: 10.12669/pjms.41.1.8496.

Characterization of phenolic compounds and evaluation of anti-diabetic potential in L. seeds: and studies.

El-Mernissi R, El Menyiy N, Metouekel A, Zouhri A, El-Mernissi Y, Siddique F Open Life Sci. 2025; 19(1):20221024.

PMID: 39822379 PMC: 11736388. DOI: 10.1515/biol-2022-1024.

References

Contreras C, Roman R, Perez C, Alarcon F, Zavala M, Perez S . Hypoglycemic activity of a new carbohydrate isolated from the roots of Psacalium peltatum. Chem Pharm Bull (Tokyo). 2005; 53(11):1408-10. DOI: 10.1248/cpb.53.1408. View

Piggott A, Karuso P . Quality, not quantity: the role of natural products and chemical proteomics in modern drug discovery. Comb Chem High Throughput Screen. 2004; 7(7):607-30. DOI: 10.2174/1386207043328409. View

Na L, Zhang Q, Jiang S, Du S, Zhang W, Li Y . Mangiferin supplementation improves serum lipid profiles in overweight patients with hyperlipidemia: a double-blind randomized controlled trial. Sci Rep. 2015; 5:10344. PMC: 4437311. DOI: 10.1038/srep10344. View

Ghazanfari-Sarabi S, Habibi-Rezaei M, Eshraghi-Naeeni R, Moosavi-Movahedi A . Prevention of haemoglobin glycation by acetylsalicylic acid (ASA): A new view on old mechanism. PLoS One. 2019; 14(4):e0214725. PMC: 6464172. DOI: 10.1371/journal.pone.0214725. View

Shaefer Jr C, Kushner P, Aguilar R . User's guide to mechanism of action and clinical use of GLP-1 receptor agonists. Postgrad Med. 2015; 127(8):818-26. DOI: 10.1080/00325481.2015.1090295. View

Kato A, Minoshima Y, Yamamoto J, Adachi I, Watson A, Nash R . Protective effects of dietary chamomile tea on diabetic complications. J Agric Food Chem. 2008; 56(17):8206-11. DOI: 10.1021/jf8014365. View

Garcia Lopez P, de la Mora P, Wysocka W, Maiztegui B, Alzugaray M, Del Zotto H . Quinolizidine alkaloids isolated from Lupinus species enhance insulin secretion. Eur J Pharmacol. 2004; 504(1-2):139-42. DOI: 10.1016/j.ejphar.2004.09.008. View

Knop F, Konings E, Timmers S, Schrauwen P, Holst J, Blaak E . Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects. Diabet Med. 2013; 30(10):1214-8. DOI: 10.1111/dme.12231. View

Lekshmi P, Arimboor R, Raghu K, Menon A . Turmerin, the antioxidant protein from turmeric (Curcuma longa) exhibits antihyperglycaemic effects. Nat Prod Res. 2011; 26(17):1654-8. DOI: 10.1080/14786419.2011.589386. View

10.

Youn J, Park H, Cho K . Anti-hyperglycemic activity of Commelina communis L.: inhibition of alpha-glucosidase. Diabetes Res Clin Pract. 2004; 66 Suppl 1:S149-55. DOI: 10.1016/j.diabres.2003.08.015. View

11.

Ames N, Blewett H, Storsley J, Thandapilly S, Zahradka P, Taylor C . A double-blind randomised controlled trial testing the effect of a barley product containing varying amounts and types of fibre on the postprandial glucose response of healthy volunteers. Br J Nutr. 2015; 113(9):1373-83. DOI: 10.1017/S0007114515000367. View

12.

Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

13.

Ghosal S, Sharma P, Chaudhuri R, Bhattacharya S . Chemical constituents of the gentianaceae V: tetraoxygenated xanthones of Swertia chirata Buch.-Ham. J Pharm Sci. 1973; 62(6):926-30. DOI: 10.1002/jps.2600620614. View

14.

Wei C, Tsai Y, Korinek M, Hung P, El-Shazly M, Cheng Y . 6-Paradol and 6-Shogaol, the Pungent Compounds of Ginger, Promote Glucose Utilization in Adipocytes and Myotubes, and 6-Paradol Reduces Blood Glucose in High-Fat Diet-Fed Mice. Int J Mol Sci. 2017; 18(1). PMC: 5297801. DOI: 10.3390/ijms18010168. View

15.

Tran N, Pham B, Le L . Bioactive Compounds in Anti-Diabetic Plants: From Herbal Medicine to Modern Drug Discovery. Biology (Basel). 2020; 9(9). PMC: 7563488. DOI: 10.3390/biology9090252. View

16.

Sohrab G, Ebrahimof S, Sotoudeh G, Neyestani T, Angoorani P, Hedayati M . Effects of pomegranate juice consumption on oxidative stress in patients with type 2 diabetes: a single-blind, randomized clinical trial. Int J Food Sci Nutr. 2016; 68(2):249-255. DOI: 10.1080/09637486.2016.1229760. View

17.

Tan J, McKenzie C, Potamitis M, Thorburn A, Mackay C, Macia L . The role of short-chain fatty acids in health and disease. Adv Immunol. 2014; 121:91-119. DOI: 10.1016/B978-0-12-800100-4.00003-9. View

18.

Andallu B, Suryakantham V, Lakshmi Srikanthi B, Reddy G . Effect of mulberry (Morus indica L.) therapy on plasma and erythrocyte membrane lipids in patients with type 2 diabetes. Clin Chim Acta. 2001; 314(1-2):47-53. DOI: 10.1016/s0009-8981(01)00632-5. View

19.

Ritu M, Nandini J . Nutritional composition of Stevia rebaudiana, a sweet herb, and its hypoglycaemic and hypolipidaemic effect on patients with non-insulin dependent diabetes mellitus. J Sci Food Agric. 2016; 96(12):4231-4. DOI: 10.1002/jsfa.7627. View

20.

Shivaprasad H, Bhanumathy M, Sushma G, Midhun T, Raveendra K, Sushma K . Salacia reticulata improves serum lipid profiles and glycemic control in patients with prediabetes and mild to moderate hyperlipidemia: a double-blind, placebo-controlled, randomized trial. J Med Food. 2013; 16(6):564-8. DOI: 10.1089/jmf.2013.2751. View